UK SARMs

UK SARMs is a United Kingdom research compound supplier with 61 listings tracked on Peptides.SO, split between 29 SARM-class research compounds and 32 peptide and ancillary listings, all priced in pounds sterling. It is one of the few UK-domiciled storefronts in the Peptides.SO supplier pool, which is otherwise mostly US-based.

Catalog shape from platform data: the SARM segment (29 listings) covers RAD-140, LGD-4033, MK-2866, MK-677, GW501516, GW0742, YK-11, S-4, S23, SR-9009, SR-9011, RAD-150 and RU58841, plus 11 pre-assembled multi-compound bundles. The peptide segment is deepest in growth-hormone-axis compounds (11 listings: CJC-1295 with and without DAC, GHRP-2, GHRP-6, Sermorelin, Tesamorelin, IGF-1 LR3, Ipamorelin/CJC and Tesamorelin/Ipamorelin blends), followed by healing and recovery (5: BPC-157 in two sizes, KPV, TB-500 10mg, a GHK-Cu/BPC-157/TB-500 blend), sexual-health research peptides (5: PT-141, Oxytocin, two Melanotan I listings and a nasal tanning product), cosmetic peptides (3), and two GLP-class compounds (Mazdutide 10mg and Retatrutide).

Where UK SARMs sits against the platform: comparing its list prices with the Peptides.SO median for the same catalogue product across every supplier that stocks it (24 products carried by at least ten suppliers), 18 of 26 comparable listings sit below the platform median and 7 above. The clearest gaps are in the peptide range: BPC-157 at £44.99 against a platform median of $95.00 across 91 suppliers, Tesamorelin at £49.99 against $84.50 (93 suppliers), MOTS-c at £49.99 against $73.50 (95 suppliers), IGF-1 LR3 at £45.99 against $72.50 (48 suppliers), Retatrutide at £109.99 (currently marked down to £94.99) against $176.50 (27 suppliers), and PT-141 at £39.99 against $46.48 (85 suppliers). Above-median entries are NAD+ at £99.00 (platform median $75.00), GHRP-6 5mg at £49.99 (median $37.44) and TB-500 10mg at £69.99 list (median $36.00 for that entry, though it is currently discounted to £49.99). These are list-price comparisons on the same catalogue entry; vial sizes are not always stated in the product name, so treat the gaps as directional and confirm the milligram amount before ordering. Sterling figures are shown as stored by the supplier and have not been converted.

Verification status on Peptides.SO: UK SARMs has not completed platform verification, holds a testing score of 0 out of 7 criteria, and has no Certificate of Analysis linked to its profile. The supplier carries a 4.0 out of 5 rating from 3 platform reviews and no payment-method data has been captured from its storefront. Researchers should request a batch-specific, third-party COA covering identity and purity before purchase and, for shipments leaving the UK, check the import rules of the destination country for both SARM-class compounds and peptides.

Common questions. Is this a peptide supplier or a SARM supplier? Both; by listing count it is roughly half and half, but the platform price advantage is concentrated on the peptide side. Which listings show the largest discount to the platform median? BPC-157, Tesamorelin, Retatrutide and IGF-1 LR3. Does UK SARMs publish third-party test results on Peptides.SO? Not at present; none of the seven testing criteria are documented on the platform.

All products offered through suppliers listed on Peptides.SO are intended exclusively for in-vitro laboratory research and are not approved, intended, or suitable for human use, animal use, clinical administration, or food production.